3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells

Journal of Controlled Release

Volumn 162, Issue 1, 2012, Pages 92-101

  Yohe, Stefan T ^a   Herrera, Victoria L M ^c   Colson, Yolonda L ^b   Grinstaff, Mark W ^a  

^a BOSTON UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomaterial; Colorectal cancer; Electrospinning; Local drug delivery; Recurrence; Superhydrophobic

Indexed keywords

AIR LAYERS; ANTICANCER DRUG; CAPROLACTONE; CELL LINES; COLORECTAL CANCER; COLORECTAL CANCER CELL; DRUG DIFFUSION; DRUG RELEASE; ELECTROSPUNS; HYDROPHOBIC POLYMERS; LOCAL DRUG DELIVERY; LOCOREGIONAL RECURRENCE; NON-INVASIVE ASSESSMENTS; RECURRENCE; REINFORCEMENT MATERIALS; SUPERHYDROPHOBIC;

BIOLOGICAL MATERIALS; BIOMATERIALS; CELL CULTURE; CHEMOTHERAPY; DISEASES; DRUG DELIVERY; DRUG PRODUCTS; ELECTROSPINNING; GLYCEROL; MECHANICAL PROPERTIES; NONINVASIVE MEDICAL PROCEDURES; STEARIC ACID; SURGERY;

HYDROPHOBICITY;

FIRTECAN; IRINOTECAN; POLY(GLYCEROLMONOSTEARATE CO EPSILONE CAPROLACTONE); POLYCAPROLACTONE; POLYMER; UNCLASSIFIED DRUG;

ANASTOMOSIS; ARTICLE; CANCER CELL; CANCER RECURRENCE; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG MECHANISM; DRUG RELEASE; DRUG STRUCTURE; ELECTROSPINNING; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL LINE, TUMOR; CELL SURVIVAL; COLORECTAL NEOPLASMS; DRUG DELIVERY SYSTEMS; GLYCEROL; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; POLYESTERS; STEARATES;

EID: 84864722770     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.05.047     Document Type: Article

References (50)

1. S.T. Yohe, Y.L. Colson, and M.W. Grinstaff Superhydrophobic materials for tunable drug release: using displacement of air to control delivery rates J. Am. Chem. Soc. 134 2012 2016 2019
2. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J. Clin. 60 2010 277 300
3. Al B. Benson III, D. Schrag, Mark R. Somerfield, Alfred M. Cohen, Alvaro T. Figueredo, Patrick J. Flynn, Monika K. Krzyzanowska, J. Maroun, P. McAllister, E. Van Cutsem, M. Brouwers, M. Charette, and Daniel G. Haller American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer J. Clin. Oncol. 22 2004 3408 3419
4. A. Sjovall, F. Granath, B. Cedermark, B. Glimelius, and T. Holm Loco-regional recurrence from colon cancer: a population-based study Ann. Surg. Oncol. 14 2007 432 440
5. C. Balch Glen, A. De Meo, and G. Guillem Jose Modern management of rectal cancer: a 2006 update World J. Gastroenterol. 12 2006 3186 3195
6. C.J. Consten Esther, M. Gagner, A. Pomp, and B. Inabnet William Decreased bleeding after laparoscopic sleeve gastrectomy with or without duodenal switch for morbid obesity using a stapled buttressed absorbable polymer membrane Obes. Surg. 14 2004 1360 1366
7. R. Langer Polymeric delivery systems for controlled drug release Chem. Eng. Commun. 6 1980 1 48
8. B.D. Weinberg, E. Blanco, and J. Gao Polymer implants for intratumoral drug delivery and cancer therapy J. Pharm. Sci. 97 2008 1681 1702
9. S. Kim, J.H. Kim, O. Jeon, I.C. Kwon, and K. Park Engineered polymers for advanced drug delivery Eur. J. Pharm. Biopharm. 71 2009 420 430
10. A.S. Hoffman The origins and evolution of controlled drug delivery systems J. Control. Release 132 2008 153 163
11. A.A. Exner, and G.M. Saidel Drug-eluting polymer implants in cancer therapy Expert Opin. Drug Deliv. 5 2008 775 788
12. R. De Souza, P. Zahedi, C.J. Allen, and M. Piquette-Miller Polymeric drug delivery systems for localized cancer chemotherapy Drug Deliv. 17 2010 365 375
13. M.A. Moses, H. Brem, and R. Langer Advancing the field of drug delivery: taking aim at cancer Cancer Cell 4 2003 337 341
14. M.E. Davis, Z. Chen, and D.M. Shin Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discov. 7 2008 771 782
15. V.P. Torchilin Multifunctional nanocarriers Adv. Drug Deliv. Rev. 58 2006 1532 1555
16. C.C. Lee, J.A. MacKay, J.M.J. Frechet, and F.C. Szoka Designing dendrimers for biological applications Nat. Biotechnol. 23 2005 1517 1526
17. Y.L. Colson, and M.W. Grinstaff Biologically responsive polymeric nanoparticles for drug delivery Adv. Mater. 2012
18. R. De Souza, P. Zahedi, C.J. Allen, and M. Piquette-Miller Polymeric drug delivery systems for localized cancer chemotherapy Drug Deliv. 17 2010 365 375
19. J.B. Wolinsky, Y.L. Colson, and M.W. Grinstaff Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers J. Control. Release 159 2012 14 26
20. R. Liu, J.B. Wolinsky, J. Walpole, E. Southard, L.R. Chirieac, M.W. Grinstaff, and Y.L. Colson Prevention of local tumor recurrence following surgery using low-dose chemotherapeutic polymer films Ann. Surg. Oncol. 17 2010 184 191
21. J.B. Wolinsky, R. Liu, J. Walpole, L.R. Chirieac, Y.L. Colson, and M.W. Grinstaff Prevention of in vivo lung tumor growth by prolonged local delivery of hydroxycamptothecin using poly(ester-carbonate)-collagen composites J. Control. Release 144 2010 280 287
22. R. Liu, B. Wolinsky Jesse, J. Catalano Paul, R. Chirieac Lucian, J. Wagner Andrew, W. Grinstaff Mark, L. Colson Yolonda, and P. Raut Chandrajit Paclitaxel-eluting polymer film reduces locoregional recurrence and improves survival in a recurrent sarcoma model: a novel investigational therapy Ann. Surg. Oncol. 19 2012 199 206
23. J. Genzer, and K. Efimenko Recent developments in superhydrophobic surfaces and their relevance to marine fouling: a review Biofouling 22 2006 339 360
24. A. Nakajima, K. Hashimoto, and T. Watanabe Recent studies on super-hydrophobic films Monatsh. Chem. 132 2001 31 41
25. X.-M. Li, D. Reinhoudt, and M. Crego-Calama What do we need for a superhydrophobic surface? A review on the recent progress in the preparation of superhydrophobic surfaces Chem. Soc. Rev. 36 2007 1350 1368
26. M. Nosonovsky, and B. Bhushan Superhydrophobic surfaces and emerging applications: non-adhesion, energy, green engineering Curr. Opin. Colloid Interface Sci. 14 2009 270 280
27. J.B. Wolinsky, W.C. Ray III, Y.L. Colson, and M.W. Grinstaff Poly(carbonate-ester)s based on units of 6-hydroxyhexanoic acid and glycerol Macromolecules 40 2007 7065 7068
28. M.E. Wall, M.C. Wani, C.E. Cook, K.H. Palmer, A.T. McPhail, and G.A. Sim Plant antitumor agents. I. Isolation and structure of camtothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata J. Am. Chem. Soc. 88 1966 3888 3890
29. Y.H. Hsiang, R. Hertzberg, S. Hecht, and L.F. Liu Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I J. Biol. Chem. 260 1985 14873 14878
30. B.C. Giovanella, J.S. Stehlin, M.E. Wall, M.C. Wani, W. Nicholas, L.F. Liu, R. Silber, and M. Potmesil DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts Science 246 1989 1046 1048
31. J.B. Wolinsky, S.T. Yohe, Y.L. Colson, and M.W. Grinstaff Functionalized hydrophobic poly(glycerol-co-ε-caprolactone) depots for controlled drug release Biomacromolecules 13 2012 406 411
32. J. Xie, and C.-H. Wang Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro Pharm. Res. 23 2006 1817 1826
33. Q.P. Pham, U. Sharma, and A.G. Mikos Electrospun poly(ε- caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds and measurement of cellular infiltration Biomacromolecules 7 2006 2796 2805
34. F.A. Scappaticci, L. Fehrenbacher, T. Cartwright, J.D. Hainsworth, W. Heim, J. Berlin, F. Kabbinavar, W. Novotny, S. Sarkar, and H. Hurwitz Surgical wound healing complications in metastatic colorectal cancer patients treated with Bevacizumab J. Surg. Oncol. 91 2005 173 180
35. M.A. Kuzu, C. Koksoy, T. Kale, E. Demirpence, and N. Renda Experimental study of the effect of preoperative 5-fluorouracil on the integrity of colonic anastomoses Br. J. Surg. 85 1998 236 239
36. Q.Y. Li, Y.G. Zu, R.Z. Shi, and L.P. Yao Review camptothecin: current perspectives Curr. Med. Chem. 13 2006 2021 2039
37. R.H.J. Mathijssen, R.J. Van Alphen, J. Verweij, W.J. Loos, K. Nooter, G. Stoter, and A. Sparreboom Clinical pharmacokinetics and metabolism of irinotecan (CPT-11) Clin. Cancer Res. 7 2001 2182 2194
38. J.F. Pizzolato, and L.B. Saltz The camptothecins Lancet 361 2003 2235 2242
39. J.A. Zhang, T. Xuan, M. Parmar, L. Ma, S. Ugwu, S. Ali, and I. Ahmad Development and characterization of a novel liposome-based formulation of SN-38 Int. J. Pharm. 270 2004 93 107
40. M.L. Rothenberg, J.G. Kuhn, H.A. Burris III, J. Nelson, J.R. Eckardt, M. Tristan-Morales, S.G. Hilsenbeck, G.R. Weiss, L.S. Smith, G.I. Rodriguez, M.K. Rock, and D.D. von Hoff Phase I and pharmacokinetic trial of weekly CPT-11 J. Clin. Oncol. 11 1993 2194 2204
41. M.L. Rothenberg, J.G. Kuhn, L.J. Schaaf, G.I. Rodriguez, S.G. Eckhardt, M.A. Villalona-Calero, D.A. Rinaldi, L.A. Hammond, S. Hodges, A. Sharma, G.L. Elfring, R.G. Petit, P.K. Locker, L.L. Miller, and D.D. von Hoff Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks Ann. Oncol. 12 2001 1631 1641
42. Y. Kawato, M. Aonuma, Y. Hirota, H. Kuga, and K. Sato Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11 Cancer Res. 51 1991 4187 4191
43. T.G. Burke, and Z. Mi Ethyl substitution at the 7 position extends the half-life of 10-hydroxycamptothecin in the presence of human serum albumin J. Med. Chem. 36 1993 2580 2582
44. C.L. Erickson-Miller, R.D. May, J. Tomaszewski, B. Osborn, M.J. Murphy, J.G. Page, and R.E. Parchment Differential toxicity of camptothecin, topotecan, and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro Cancer Chemother. Pharmacol. 39 1997 467 472
45. Z. Jambrik, S. Monti, V. Coppola, E. Agricola, G. Mottola, M. Miniati, and E. Picano Usefulness of ultrasound lung comets as a nonradiologic sign of extravascular lung water Am. J. Cardiol. 93 2004 1265 1270
46. B.W. Tillman, S.K. Yazdani, S.J. Lee, R.L. Geary, A. Atala, and J.J. Yoo The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction Biomaterials 30 2009 583 588
47. W.S.W. Shalaby, W.E. Blevins, and K. Park Use of ultrasound imaging and fluoroscopic imaging to study gastric retention of enzyme-digestible hydrogels Biomaterials 13 1992 289 296
48. J. Zeng, L. Yang, Q. Liang, X. Zhang, H. Guan, X. Xu, X. Chen, and X. Jing Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation J. Control. Release 105 2005 43 51
49. A. Tanizawa, A. Fujimori, Y. Fujimori, and Y. Pommier Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials J. Natl. Cancer Inst. 86 1994 836 842
50. H. Brem Polymers to treat brain tumours Biomaterials 11 1990 699 701